Glucose Transporter Type 1 (Glut1) Deficiency Syndrome Rare, But Treatable-Ketogenic Dietary Therapy as First-Line Therapy

被引:0
作者
Schonlaub, A. [1 ]
Holler, A. [2 ]
Karall, D. [3 ]
Klepper, J. [4 ]
Scholl-Burgi, S. [3 ]
机构
[1] Med Univ Innsbruck, Dept Kinder & Jugendheilkunde, Padiatrie 1, Neuropadiatrie, Innsbruck, Austria
[2] Ao Landeskrankenhaus Innsbruck, Univ Kliniken Innsbruck, Diatol Ernahrungsmed, Innsbruck, Austria
[3] Med Univ Innsbruck, Tirol Kliniken GmbH, Dept Kinder & Jugendheilkunde, Klin Padiatrie 1 Angeborene Stoffwechselstorungen, Anichstr 35, A-6020 Innsbruck, Austria
[4] Klinikum Aschaffenburg Alzenau, Klin Kinder & Jugendmed, Dept Padiatrie & Neuropadiatrie, Aschaffenburg, Germany
来源
PADIATRIE UND PADOLOGIE | 2022年 / 57卷 / 01期
关键词
Glucose-1 transporter defect; Refractory seizures; Ketogenic diet; Ketogenic dietary therapies; Movement disorders; GLUCOSE-TRANSPORTER-1; DEFICIENCY; SLC2A1; MUTATIONS; DIAGNOSIS; SEIZURES; ABSENCE;
D O I
10.1007/s00608-021-00958-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Glut1 Deficiency Syndrome (Glut1-DS) is a rare metabolic disease that leads to complex encephalopathy. This is due to heterozygous, de novo mutations in theSLC2A1 gene in the majority of cases. The absence or reduced function of glucose transporter type 1 (GLUT1) causes an energy deficiency of the central nervous system (CNS), as not enough glucose is transported across the blood-brain barrier. The disease usually becomes apparent through cerebral seizures (such as absences or myoclonic-astatic seizures) in infancy and early childhood. Characteristic initial symptoms of the disease are also paroxysmal eye-head movements in infants. There is usually a global developmental impairment with a complex cerebral movement disorder; its main components are ataxia, dystonia, spasticity, and dysarthria. Some of the most severely affected patients develop secondary microcephaly. Some symptoms improve after meals because of the postprandial increase in the level of blood glucose. Symptoms are age related-in infancy and early childhood epilepsy is dominant, in adolescents and adults it is cerebral movement disorders. Diagnosis is based on: 1. typical clinical signs; 2. decreased CSF glucose in the presence of normoglycaemia; and 3. detection of a pathogenic variant of SLC2A1 gene. When Glut1-DS is strongly suspected or diagnosed, therapy must be initiated immediately to reach optimal cognitive development. As the CNS can use ketone bodies as an alternative source of energy instead of glucose, ketogenic dietary therapies (KDTs) are the treatment of choice. In the KDTs (classical ketogenic diet, modified Atkins diet), ketogenesis is induced by a high-fat and low-carbohydrate diet. Depending on the age of the patient, the compliance of the patient and his family, and the efficacy of the KDT, either the classic ketogenic diet or the Atkins diet is applied to achieve sufficient ketosis. The KDT should be continued at least until early adulthood.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 19 条
  • [1] Diagnosing Glucose Transporter 1 Deficiency at Initial Presentation Facilitates Early Treatment
    Akman, Cigdem Inan
    Yu, Julia
    Alter, Aliza
    Engelstad, Kristin
    De Vivo, Darryl C.
    [J]. JOURNAL OF PEDIATRICS, 2016, 171 : 220 - 226
  • [2] The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels
    Christodoulides, S. S.
    Neal, E. G.
    Fitzsimmons, G.
    Chaffe, H. M.
    Jeanes, Y. M.
    Aitkenhead, H.
    Cross, J. H.
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2012, 25 (01) : 16 - 26
  • [3] Seizures, ataxia, developmental delay and the general paediatrician: Glucose transporter 1 deficiency syndrome
    Coman, DJ
    Sinclair, KG
    Burke, CJ
    Appleton, DB
    Pelekanos, JT
    O'Neil, CM
    Wallace, GB
    Bowling, FG
    Wang, D
    De Vivo, DC
    McGill, JJ
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (05) : 263 - 267
  • [4] Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome
    De Giorgis, Valentina
    Masnada, Silvia
    Varesio, Costanza
    Chiappedi, Matteo A.
    Zanaboni, Martina
    Pasca, Ludovica
    Filippini, Melissa
    Macasaet, Joyce A.
    Valente, Marialuisa
    Ferraris, Cinzia
    Tagliabue, Anna
    Veggiotti, Pierangelo
    [J]. BRAIN AND BEHAVIOR, 2019, 9 (03):
  • [5] Glut1 deficiency: CSF glucose. How low is too low?
    De Vivo, D. C.
    Wang, D.
    [J]. REVUE NEUROLOGIQUE, 2008, 164 (11) : 877 - 880
  • [6] DEFECTIVE GLUCOSE-TRANSPORT ACROSS THE BLOOD-BRAIN-BARRIER AS A CAUSE OF PERSISTENT HYPOGLYCORRHACHIA, SEIZURES, AND DEVELOPMENTAL DELAY
    DEVIVO, DC
    TRIFILETTI, RR
    JACOBSON, RI
    RONEN, GM
    BEHMAND, RA
    HARIK, SI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) : 703 - 709
  • [7] A Simple Blood Test Expedites the Diagnosis of Glucose Transporter Type 1 Deficiency Syndrome
    Gras, Domitille
    Cousin, Christelle
    Kappeler, Caroline
    Fung, Cheuk-Wing
    Auvin, Stephane
    Essid, Nouha
    Chung, Brian Hy
    Da Costa, Lydie
    Hainque, Elodie
    Luton, Marie-Pierre
    Petit, Vincent
    Vuillaumier-Barrot, Sandrine
    Boespflug-Tanguy, Odile
    Roze, Emmanuel
    Mochel, Fanny
    [J]. ANNALS OF NEUROLOGY, 2017, 82 (01) : 133 - 138
  • [8] 10 patients, 10 years - Long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: A prospective, multicenter case series
    Heussinger, Nicole
    Della Marina, Adela
    Beyerlein, Andreas
    Leiendecker, Baerbel
    Hermann-Alves, Sofia
    Dalla Pozza, Robert
    Klepper, Joerg
    [J]. CLINICAL NUTRITION, 2018, 37 (06) : 2246 - 2251
  • [9] Nationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan
    Ito, Yasushi
    Takahashi, Satoru
    Kagitani-Shimono, Kuriko
    Natsume, Jun
    Yanagihara, Keiko
    Fujii, Tatsuya
    Oguni, Hirokazu
    [J]. BRAIN & DEVELOPMENT, 2015, 37 (08) : 780 - 789
  • [10] Use of dietary therapies amongst patients with GLUT1 deficiency syndrome
    Kass, Hannah R.
    Winesett, S. Parrish
    Bessone, Stacey K.
    Turner, Zahava
    Kossoff, Eric H.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2016, 35 : 83 - 87